Renewing Koselugo (Selumetinib) Approval with UnitedHealthcare in Washington: 2025 Requirements & Timeline
Answer Box: Renewing Koselugo with UnitedHealthcare in Washington
UnitedHealthcare requires prior authorization renewal for Koselugo (selumetinib) every 12 months for pediatric NF1 patients. Start renewal 30-60 days early with updated MRI showing stable/improved plexiform neurofibromas, specialist notes documenting continued benefit, and cardiac/eye monitoring results. Submit through the UnitedHealthcare